WEE1 and colorectal carcinoma: Assuming that the same mechanisms can be translated in CRC and that WEE1 inhibitors have a strong biological rationale for CRC treatment, the positive results of AZD1775, combined with radiotherapy in pancreatic cancer, support the testing and further investigation of this combination therapy in CRC.